XML 45 R67.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Shareholders' Equity - Schedule of Stock Options Expected To Vest, Stock Options Exercisable, and Unvested Restricted Share Awards Expected To Vest (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Weighted Average Exercise Price, Number of stock options expected to vest $ 34.50    
Weighted Average Exercise Price, Total stock options exercisable - December 31, 2019 $ 38.62 $ 16.01 $ 15.40
Number of stock options expected to vest 3,030,071    
Number of Restricted Shares expected to vest 569,770    
Weighted Average Remaining Life (Years), Number of stock options expected to vest 4 years    
Weighted Average Remaining Life (Years), Total stock options exercisable - December 31, 2019 3 years 7 months 6 days    
Stock Options      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Number of stock options expected to vest 3,030,071    
Total stock options exercisable - December 31, 2019 1,435,088    
Unrecognized compensation cost - December 31, 2019 $ 5,884    
Weighted average years over which unrecognized compensation cost will be recognized 1 year 10 months 24 days    
RSAs      
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Weighted average years over which unrecognized compensation cost will be recognized 2 years 10 months 24 days    
Number of Restricted Shares expected to vest 569,770    
Unrecognized compensation cost - December 31, 2018 $ 19,697